Agenda
Welcome and Introduction
CDOS
- Walk through agenda
- Encourage questions through the chat
- Key discussion point
16:00 - 16:02 (CET)
Setting the scene
KTSN
- Wegovy and context of 7.2mg
- Company announcement & Media reactions
- Portfolio message
16:02 - 16:07 (CET)
STEP UP briefing
SQKL
- Trail basics
- Key results
16:07 - 16:14 (CET)
What does this mean
SQKL & NSAB
- Scientific communication of results at Conference
- Affiliate Medical and scientific communication
- Guidance to commercial activities
16:14 - 16:19 (CET)
Affiliate Commercial
JPIO & VSGT
- What excites you the most?
- What opportunities do you see for 7.2mg? (Role to address unmet need in context of competition)
16:19 - 16:25 (CET)
Summary incl. Does & Dont's
KTSN
16:25 - 16:27 (CET)
Q&A
All/CDOS
- Introduce Narrative of CagriSema (KTSN/NSAB)
- Prepared question from Q&A documents
- Feed questions via chat into studio
16:27 - 16:37 (CET)
Wrap up
CDOS
16:37 - 16:38 (CET)